News
Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed ...
11h
Zacks Investment Research on MSNCompany News for Jul 9, 2025U.S-based copper mining company Freeport-McMoRan Inc. FCX gained 2.5% on Trump’s tariff threats on imported copper. Shares of Moderna, Inc. MRNA gained 8.8% on leading medical organizations filing a ...
The S&P 500 fell 0.1% on Tuesday, July 8, 2025, after President Trump extended the deadline for "reciprocal" tariffs and ...
1d
Barchart on MSNThe Next Moderna? This Clinical-Stage Biotech Has Breakout Potential.Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...
The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Hearing aids dramatically improve a person's social engagement and reduce feelings of isolation or loneliness, based on ...
We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results